Report finds UK risks falling behind rivals in life sciences
A just-published report on the UK’s life sciences sector “ought to ring alarm bells across government,” according to the Association of the British Pharmaceutical Industry […]
A just-published report on the UK’s life sciences sector “ought to ring alarm bells across government,” according to the Association of the British Pharmaceutical Industry […]
If you’re in business, you have competitors. Whether you represent a hospital, health system, or multilocation practice, competing healthcare businesses are developing innovative business models—right […]
If you’re in business, you have competitors. Whether you represent a hospital, health system, or multilocation practice, competing healthcare businesses are developing innovative business models—right […]
If you’re in business, you have competitors. Whether you represent a hospital, health system, or multilocation practice, competing healthcare businesses are developing innovative business models—right […]
The UK Competition and Markets Authority has ruled that several drugmakers worked together to raise the NHS price of widely-used nausea drug prochlorperazine, fining them […]
About 73% of health insurance markets are highly concentrated, and in 46% of markets, one insurer had a share of 50% or more, a new […]
The FTC sued to block the merger between the two New Jersey-based health systems and won a preliminary injunction earlier this month. But the providers […]
AbbVie will not be pursued any further by the US government over allegations that it used ‘sham’ litigation to keep competition to its AndroGel testosterone […]
The UK has levied another big fine for anticompetitive activity in the pharma market in a fortnight, with Advanz Pharma and former owners on the […]
The UK’s competition authority has issued its largest ever fine of more than £260 million ($360 million) to several pharma companies accused of colluding to […]
President Joe Biden has signed a new executive order to tackle anti-competitive behavior across American industries. With regard to healthcare, Biden is directing federal agencies […]
Patients are not the only ones who will benefit from the price transparency rule — providers and payers can also gain competitive advantages as a […]
Mylan’s $12 billion takeover of Pfizer’s Upjohn unit has been cleared by the US authorities, but on the condition that the two companies divest various […]
Copyright © 2024 | WordPress Theme by MH Themes